| BCBS Highmark West Virginia | Autologous Cellular Immunotherapy for Prostate Cancer | 2026-06-01 |
| BCBS Highmark West Virginia | Chimeric Antigen Receptor T-Cell and T-Cell Receptor Therapies | 2026-06-01 |
| UHC Commercial Medical & Drug | Ambulance Services – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Breast Reduction Surgery – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Catheter Ablation for Atrial Fibrillation – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Chromosome Microarray Testing (Non-Oncology Conditions) – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Cochlear Implants – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Cosentyx® (Secukinumab) – Commercial Medical Benefit Drug Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Cosmetic and Reconstructive Procedures – Commercial and Individual Exchange Medical Policy | 2026-06-01 |
| UHC Commercial Medical & Drug | Gastrointestinal Disorders Diagnostic Procedures – Commercial and Individual Exchange Medical Policy | 2026-06-01 |